Investigation of Antibody-Drug Conjugates by Mass Spectrometry

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

ADCs are empowered monoclonal antibodies that are designed to harness their targeting ability by linking them to cell-killing agents. They are made up of three main components, the antibody, linker and the cytotoxic drug. The specificity of the antibody with the antigen on the tumor cell surface helps with its internalization into the cell after which the active drug is released causing cell death. The investigation of ADCs can be done using a variety of MS methods. Here, we talk about the bottom-up approach, the top-down approaches such as ECD and ETD, the ESI/MS method and IM-MS. Further, we also focus on the applications of MALDI/MS such as UV-MALDI, IR-MALDI and IMS-MALDI and provide examples of the mass spectra that provide tremendous amount of information on ADC structures.

Cite

CITATION STYLE

APA

Jayathirtha, M., & Darie, C. C. (2019). Investigation of Antibody-Drug Conjugates by Mass Spectrometry. Advances in Experimental Medicine and Biology, 1140, 251–263. https://doi.org/10.1007/978-3-030-15950-4_14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free